Open AccessDiscordant PET Findings and a High Relapse Rate Characterize Hispanics With Hodgkin’s Lymphoma Treated With ABVD
Author(s) -
Sumit Gaur,
Alexander Philipovskiy,
Onyedika Umeanaeto,
Anna M. Eiring,
Alok Dwivedi,
Attilio Orazi
Publication year - 2021
Publication title -
cancer diagnosis and prognosis
Language(s) - English
Resource type - Journals
ISSN - 2732-7787
DOI - 10.21873/cdp.10017
Subject(s) - abvd , medicine , dacarbazine , vinblastine , hodgkin's lymphoma , chemotherapy regimen , regimen , interquartile range , population , oncology , nuclear medicine , lymphoma , chemotherapy , vincristine , cyclophosphamide , environmental health
Population-based studies on Hodgkin's lymphoma (HL) have shown reduced survival in Hispanics and non-Hispanic Blacks compared with non-Hispanic Whites. To better understand the factors contributing to this outcome discrepancy, we retrospectively reviewed the charts of patients with HL diagnosed and treated at a single institution located along the Texas-Mexico border.